Nanoparticles squeezing across the blood-endothelial barrier via caveolae

Therapeutic Delivery

Volumn 4, Issue 2, 2013, Pages 131-133

  Wang, Zhenjia ^a   Malik, Asrar B ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

caveolae; caveolae mediated transport; endothelial barrier; nanotherapeutics

Indexed keywords

ALBUMIN; CAVEOLIN 1; DENDRIMER; NANOPARTICLE; POLYSTYRENE;

BLOOD ENDOTHELIAL BARRIER; CAVEOLA; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG TRANSPORT; ENDOTHELIUM CELL; INTERNALIZATION; MATERIAL COATING; PARTICLE SIZE; PERMEABILITY BARRIER; PRIORITY JOURNAL; REVIEW; TRANSCYTOSIS; TRANSPORT KINETICS; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

EID: 84872957987     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.12.140     Document Type: Review

References (20)

1. Faokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano 3, 16-20 (2009).
2. Wang X, Yang L, Chen Z, Shin DM. Application of nanotechnology in cancer therapy and imaging. CA Cancer J. Clin. 58, 97-110 (2008). (Pubitemid 351521865)
3. Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol. Rev. 86, 279-367, 2006 (2006).
4. Giordano RJ, Edwards JK, Tuder RM, Arap W, Renata Pasqualini R. Combinatorial ligand-directed lung targeting. Proc. Am. Thorac. Soc. 6(5), 411-415 (2009).
5. Hashizume H, Baluk P, Morikawa S et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am. J. Pathol. 156, 1363-1380 (2000). (Pubitemid 30660013)
6. Sarin H, Kanevsky AS, Wu H et al. Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors. J. Trans. Med. 7, 51-63 (2009).
7. Zetter BR. Endothelial heterogeneity: influence of vessel size, organ localization and species specificity on the properties of cultured endothelial cells. In: Endothelial Cells Volume 2. Ryan US (Ed.). CRC Press, Boca Raton, FL, USA, 63-79 (1989).
8. Sandoval KE, Witt KA. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol. Dis. 32, 200-219 (2008).
9. Komarova Y, Malik AB. Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu. Rev. Physiol. 72, 463-493 (2010).
10. Johansson BR. Size and distribution of endothelial plasmalemmal vesicles in consecutive segments of the microvasculature in cat skeletal muscle. Microvasc. Res. 17, 107-117 (1979). (Pubitemid 9172347)
11. Parton RG, Simons K. The multiple faces of caveolae. Nat. Rev. Mol. Cell. Biol. 8, 185-194 (2007).
12. Pelkmans L, Zerial M. Kinase-regulated quantal assemblies and kiss-and-run recycling of caveolae. Nature 436, 128-133 (2005). (Pubitemid 40966198)
13. Pelkmans L, Kartenbeck J, Helenius A. Caveolar endocytosis of simian virus 40 reveals a new two-step vescular-transport pathway to the ER. Nat. Cell Biol. 3, 573-483 (2001).
14. Hill MM, Bastiani M, Luetterforst R et al. PTRF-cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell 132, 113-124 (2008).
15. Wang Z, Tiruppathi T, Minshall R, Malik AB. Size and dynamics of caveolae using nanoparticles in living endothelial cells. ACS Nano 3, 4110-4116 (2009).
16. Wang Z, Tiruppathi C, Cho J, Minshall RD, Malik AB. Delivery of nanoparticle-complexed drugs across vascular endothelial barrier via caveolae. IUBMB Life 63, 659-667 (2011).
17. Tiruppathi C, Song W, Bergenfeldt M, Sass P, Malik AB. Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway. J. Biol. Chem. 272, 25968-25975 (1997). (Pubitemid 27438924)
18. Minshall RD, Sessa WC, Stan RV, Anderson RG, Malik AB. Caveolin regulation of endothelial function. Am. J. Physiol. Lung Cell Mol. Physiol. 285, L1179-L1183 (2003). (Pubitemid 37448786)
19. Predescu SA, Predescu DN, Malik AB. Molecular determinants of endothelial transcytosis and their role in endothelial permeability. Am. J Physiol. Lung. Cell. Mol. Physiol. 293, L823-L842 (2007). (Pubitemid 47572231)
20. Hidalgo A, Chang J, Jang JE, Peired AJ, Chiang EY, Frenett PS. Heterotypic interactions enabled by polarized neutrophils microdomains mediate thromboinflammatory injury. Nat. Med. 15, 384-391 (2009).